254
G. S. M. Sundaram et al.
LETTER
Rogers, J. W.; Cusido, J.; Abdel-Fattah, A. A. A.; Steel, P. J.
(S)-5-Benzyl-3-[2-(1H-indol-3-yl)ethyl]-1-(4-
J. Org. Chem. 2005, 70, 7866.
(9) General Procedure for the Preparation of 3,5-
Substituted 2-Thiohydantoins 4.
methoxybenzyl)-2-thioxoimidazolidin-4-one (7c).
Yield 91% (0.85 g); yellow solid; mp 170–171 °C; Rf = 0.56
(5:1 hexane–EtOAc). IR (KBr): 3404, 2927, 1750, 1473,
1350, 1263, 739 cm–1. [a]D25 –13.1 (c 0.1, CHCl3). 1H NMR
(400 MHz, CDCl3): d = 2.69–2.83 (m, 2 H), 2.92 (dd,
J = 14.52, 5.40 Hz, 1 H), 3.12 (dd, J = 14.54, 4.40 Hz, 1 H),
3.77 (s, 3 H), 3.92–3.98 (m, 2 H), 4.00 (t, J = 4.64 Hz, 1 H),
4.15 (d, J = 14.88 Hz, 1 H), 5.87 (d, J = 14.88 Hz, 1 H), 6.81
(d, J = 8.52 Hz, 2 H), 6.98 (d, J = 1.96 Hz, 1 H), 7.05 (d,
J = 7.46 Hz, 2 H), 7.07 (dd, J = 5.60, 2.20 Hz, 2 H), 7.10 (t,
J = 7.84 Hz, 1 H), 7.17 (t, J = 8.08 Hz, 1 H), 7.24 (t, J = 7.32
Hz, 3 H), 7.31 (d, J = 7.56 Hz, 1 H), 7.74 (d, J = 7.80 Hz, 1
H), 8.0 (br s, 1 H). 13C NMR (100 MHz, CDCl3): d = 22.9,
35.1, 42.3, 47.7, 55.2, 61.1, 111.0, 112.2, 114.2, 119.0,
119.4, 121.9, 122.1, 126.8, 127.4, 127.5, 128.6, 129.3,
129.6, 133.9, 136.0, 159.4, 172.7, 182.6. MS-FAB: m/z
(%) = 470 (50) [M + 1], 121 (65). ESI-HRMS: m/z calcd for
C28H27N3O2SNa: 492.1722 [M + Na]+; found: 492.1762.
(S)-1-Furan-2-ylmethyl-3-[2-(1H-indol-3-yl)ethyl]-5-
isopropyl-2-thioxoimidazolidin-4-one (7f).
Yield 82% (0.62 g); white solid; mp 143–144 °C; Rf = 0.56
(5:1 hexane–EtOAc). IR (KBr): 3332, 1712, 1466, 1356,
1288, 1258, 1222, 1148, 1005, 747 cm–1. [a]D25 –17.2 (c 0.1,
CHCl3). 1H NMR (400 MHz, CDCl3): d = 0.76 (d, J = 6.84
Hz, 3 H), 1.14 (d, J = 7.08 Hz, 3 H), 2.34–2.41 (m, 1 H),
3.05–3.17 (m, 2 H), 3.77 (d, J = 3.40 Hz, 1 H), 4.09 (t,
J = 8.32 Hz, 2 H), 4.42 (d, J = 15.60 Hz, 1 H), 5.67 (d,
J = 15.60 Hz, 1 H), 6.34 (dd, J = 3.12, 1.96 Hz, 1 H), 6.37 (d,
J = 3.16 Hz, 1 H), 7.07 (s, 1 H), 7.12 (dd, J = 7.08, 1.00 Hz,
1 H), 7.17 (dt, J = 7.94, 1.24 Hz, 1 H), 7.32 (d, J = 7.58 Hz,
1 H), 7.37 (d, J = 1.34 Hz, 1 H), 7.80 (d, J = 7.84 Hz, 1 H),
7.98 (br s, 1 H). 13C NMR (100 MHz, CDCl3): d = 15.6, 17.3,
23.5, 28.8, 41.1, 42.4, 65.8, 109.8, 110.6, 111.0, 112.2,
119.1, 119.4, 122.0, 122.2, 127.5, 136.1, 142.8, 148.5,
172.3, 182.7. MS-FAB: m/z (%) = 382 (100) [M + 1]. ESI-
HRMS: m/z calcd for C21H23N3O2SNa: 404.1409 [M + Na]+;
found: 404.1436.
A solution of L-amino acid ethyl ester hydrochloride salt 1
(2.0 mmol), amine 2 (2.0 mmol), 1-(methyldithio-
carbonyl)imidazole 3 (0.32 g, 2.0 mmol) and Et3N (0.58 mL,
4.2 mmol) in 15.0 mL of absolute EtOH was refluxed for 7–
8 h (monitored by TLC). The reaction mixture was cooled to
r.t. and concentrated under vacuo. The residue was dissolved
in CHCl3 (25 mL) and washed with H2O (2 × 20 mL), brine
(20 mL), dried (Na2SO4) and concentrated under reduced
pressure to afford the crude 4a–t, which were purified by
column chromatography over silica gel using hexane–
EtOAc as eluent. All the newly synthesized thiohydantoins
4a,b,e,f,h–t, 7a–i and 10a–c were characterized with the
help of spectral and analytical data.
(S)-3-Furan-2-ylmethyl-5-isobutyl-2-thioxo-
imidazolidin-4-one (4f).
Yield 92% (0.46 g); white solid; mp 132–133 °C; Rf = 0.73
(5:1 hexane–EtOAc). IR (KBr): 3185, 3004, 2958, 1754,
1527, 1430, 1342, 1169, 738 cm–1. [a]D25 –2.6 (c 0.5,
CHCl3). 1H NMR (400 MHz, CDCl3): d = 0.92 (d, J = 2.44
Hz, 3 H), 0.93 (d, J = 2.44 Hz, 3 H), 1.52–1.59 (m, 1 H),
1.71–1.83 (m, 2 H), 4.12 (dd, J = 9.34, 2.72 Hz, 1 H), 4.93
(d, J = 15.12 Hz, 1 H), 4.98 (d, J = 15.12 Hz, 1 H, CH2), 6.27
(dd, J = 3.16, 1.96 Hz, 1 H), 6.35 (dd, J = 3.40 Hz, 1 H), 7.30
(d, J = 0.72 Hz, 1 H), 8.20 (br s, 1 H). 13C NMR (100 MHz,
CDCl3): d = 21.3, 22.9, 25.0, 37.4, 40.1, 57.9, 109.4, 110.3,
142.3, 148.5, 174.0, 182.9. MS-FAB: m/z (%) = 253 (100)
[M + 1]. ESI-HRMS: m/z calcd for C12H16N2O2SNa:
275.0830 [M + Na]+; found: 275.0838.
(S)-3-[2-(3,4-Dimethoxyphenyl)ethyl]-5-isopropyl-2-
thioxoimidazolidin-4-one (4i).
Yield 89% (0.57 g); colorless solid; mp 114–115 °C; Rf =
0.76 (5:1 hexane–EtOAc). IR (KBr): 3188, 2949, 1747,
1515, 1441, 1350, 1269, 1152, 1028 cm–1. [a]D –5.4 (c 0.5,
25
CHCl3). 1H NMR (400 MHz, CDCl3): d = 0.82 (d, J = 6.84
Hz, 3 H), 1.01 (d, J = 7.08 Hz, 3 H), 2.13–2.24 (m, 1 H), 2.90
(t, J = 8.08 Hz, 2 H), 3.82 (s, 3 H), 3.86 (s, 3 H), 3.91 (dd,
J = 4.04, 1.20 Hz, 1 H), 3.94–4.08 (m, 2 H), 6.76 (s, 1 H),
6.78 (dd, J = 4.40, 1.72 Hz, 2 H), 7.72 (br s, 1 H). 13C NMR
(100 MHz, CDCl3): d = 16.1, 18.6, 30.6, 33.0, 42.1, 55.8,
64.4, 111.1, 112.0, 120.9, 130.1, 147.7, 148.7, 173.3, 184.1.
MS-FAB: m/z (%) = 323 (100) [M + 1]. ESI-HRMS: m/z
calcd for C16H22N2O3SNa: 345.1249 [M + Na]+; found:
345.1215.
(S)-2-Benzyl-3-thioxohexahydropyrrolo[1,2-c]imidazol-
1-one (10a).
Yield 92% (0.45 g); white solid; mp 80–81 °C; Rf = 0.70 (5:1
hexane–EtOAc). IR (KBr): 3055, 2971, 2932, 1741, 1457,
1346, 1246, 1263, 1222, 1167, 962 cm–1. [a]D25 –16.6 (c 0.1,
CHCl3). 1H NMR (400 MHz, CDCl3): d = 1.55–1.63 (m, 1
H), 2.03–2.09 (m, 1 H), 2.11–2.22 (m, 2 H), 3.47 (ddd,
J = 11.78, 8.68, 3.16 Hz, 1 H), 3.83–3.90 (m, 1 H), 4.09 (dd,
J = 10.28, 6.84 Hz, 1 H), 4.83 (d, J = 14.64 Hz, 1 H), 4.93 (d,
J = 14.64 Hz, 1 H), 7.15–7.24 (m, 3 H), 7.34–7.36 (m, 2 H).
13C NMR (100 MHz, CDCl3): d = 26.6, 44.9, 48.2, 64.9,
127.7, 128.3, 128.5, 135.7, 173.3, 186.6. MS-FAB: m/z
(%) = 247 (100) [M + 1]. ESI-HRMS: m/z calcd for
C13H14N2OSNa: 269.0724 [M + Na]+; found: 269.0723.
(11) Optical rotation of 4o [a]D25 –46.7 (c 0.225, MeOH) was
compared with the reported value [a]D25 –40.5 (c 0.225,
MeOH). See: Poupaert, J. H.; Cavalier, R.; Claesen, M. H.;
Dumont, P. A. J. Med. Chem. 1975, 18, 1268.
(10) General Procedure for the Preparation of 1,3,5-
Trisubstituted 2-Thiohydantoins 7 and N-Substituted
Fused 3-Thiohydantoins 10.
A solution of appropriate amine 2 (2.0 mmol) and 1-(methyl-
dithiocarbonyl)imidazole (3, 0.32 g, 2.0 mmol) in 10 mL of
absolute EtOH (or MeOH) was refluxed for 30 min. After
the complete consumption of 3 (as shown by TLC), a
mixture of appropriate N-substituted amino ester 6 (2.0
mmol) or L-proline methyl ester hydrochloride 9 (0.33 g, 2.0
mmol) and Et3N (0.58 mL, 4.2 mmol) in 5 mL absolute
EtOH (or MeOH) was added and the reaction mixture was
further refluxed for 6–7 h (monitored by TLC). It was then
worked up and purified as described above to afford the
products 7a–i or 10a–c.
(12) The optical purity was determined by chiral HPLC
[Chiralcel OD column, hexane–2-PrOH, 9:1]; ee (%): 4a,
64; 4f, 58; 4g, 95; 7c, 58; 7f, >99; 10a, >99.
Synlett 2007, No. 2, 251–254 © Thieme Stuttgart · New York